News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Recipharm AB Launches Enhanced Product Recovery Service


4/27/2012 6:29:10 AM

27th April 2012 - Recipharm Ltd in Ashton under Lyne, UK is pleased to launch a dedicated recovery service for reworking pharmaceutical products under cGMP conditions at its UK site.

This bespoke service is now available following a number of requests from customers and will include:

Data matrix serialization

De-labelling and re-labelling

De-blistering and re-blistering

Unpacking and repackaging

Bundelling

Re-tightening caps

Heat sealing caps

Re-counting

Check weighing

Re-coding

Metal detection in bulk tablet and capsule product.

The facility is fully licensed by the MHRA with on site Qualified Persons and regulatory staff.

We can offer support in making batch specific variations to the Regulatory Authorities.

“Recipharm Ashton’s product recovery team offers rapid, flexible and cost effective solutions that are tried and tested, can avoid costly product re-working in-house, saving time and potentially avoiding write off costs”. Iain Martin, General Manager Recipharm Ltd. commented

About Recipharm

Recipharm AB is a leading contract development and manufacturing organization (CDMO) based in Sweden employing some 1700 employees. The Company operates development and manufacturing facilities in Sweden, France, the UK, Germany and Spain and is headquartered near Stockholm. Recipharm supplies the global pharmaceuticals market with hundreds of different products in multiple dosage forms that include solid dose, granulates and powders, sterile liquids and lyophilisates, semi solids, beta-lactams, hormones, oral liquids, sprays and dry powder inhalers. For more information visit; www.recipharm.com

Contact information

Dewi Lewis, E-mail : dewi.lewis@recipharm.com, Tel :+44 (0) 161 342 6433

For media enquiries, please contact Tristan Jervis or Alex Heeley at De Facto Communications on:

E-mail: t.jervis@defacto.com or a.heeley@defacto.com

Tel: +44 (0) 207 861 3019/3043


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES